News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
222,288 Results
Type
Article (5121)
Company Profile (22)
Press Release (217145)
Section
Business (82374)
Career Advice (462)
Deals (15075)
Drug Delivery (11)
Drug Development (19123)
Employer Resources (30)
FDA (3720)
Job Trends (3920)
News (120425)
Policy (7551)
Tag
Academia (293)
Alliances (14786)
Alzheimer's disease (217)
Approvals (3714)
Bankruptcy (94)
Best Places to Work (2864)
Biosimilars (39)
Biotechnology (24)
Cancer (242)
Career advice (392)
Cell therapy (55)
Clinical research (15738)
Collaboration (86)
Compensation (67)
COVID-19 (296)
C-suite (47)
Data (291)
Diabetes (24)
Diagnostics (2010)
Earnings (40026)
Employer resources (31)
Events (37045)
Executive appointments (136)
FDA (3831)
Funding (94)
Gene therapy (25)
GLP-1 (97)
Government (417)
Healthcare (5027)
Infectious disease (307)
Inflammatory bowel disease (23)
Interviews (53)
IPO (7756)
Job creations (1128)
Job search strategy (361)
Layoffs (97)
Legal (2331)
Lung cancer (27)
Manufacturing (34)
Medical device (3838)
Medtech (3839)
Mergers & acquisitions (7360)
Metabolic disorders (74)
Neuroscience (263)
NextGen Class of 2024 (1677)
Non-profit (726)
Northern California (532)
Obesity (36)
Opinion (30)
People (24204)
Phase I (4693)
Phase II (6838)
Phase III (5438)
Pipeline (263)
Postmarket research (627)
Preclinical (1834)
Press Release (66)
Radiopharmaceuticals (104)
Rare diseases (38)
Real estate (1879)
Regulatory (5018)
Research institute (302)
Resumes & cover letters (68)
Southern California (404)
Startups (1012)
United States (4241)
Vaccines (25)
Date
Last 7 days (169)
Last 30 days (1208)
Last 365 days (11225)
2024 (10407)
2023 (13256)
2022 (18751)
2021 (19764)
2020 (18339)
2019 (13284)
2018 (10276)
2017 (10057)
2016 (9220)
2015 (12166)
2014 (9608)
2013 (7722)
2012 (8341)
2011 (8806)
2010 (8637)
Location
Africa (182)
Arizona (49)
Asia (11589)
Australia (1563)
California (1085)
Canada (458)
China (31)
Colorado (42)
Connecticut (56)
Europe (24063)
Florida (139)
Georgia (22)
Idaho (23)
Illinois (77)
Indiana (35)
Japan (30)
Kansas (23)
Maine (34)
Maryland (139)
Massachusetts (900)
Michigan (60)
Minnesota (98)
New Jersey (336)
New York (303)
North Carolina (239)
Northern California (532)
Ohio (36)
Pennsylvania (227)
South America (273)
Southern California (404)
Texas (130)
Utah (31)
Washington State (98)
222,288 Results for "samsung corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Samsung Biologics signs manufacturing deal with European pharmaceutical company
November 20, 2024
·
3 min read
Policy
FDA Approves PYZCHIVA® (ustekinumab-ttwe), Samsung Bioepis’ Biosimilar to Stelara
Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration has approved the Biologics License Application for PYZCHIVA® subcutaneous injection and intravenous infusion as a biosimilar to Stelara.
July 1, 2024
·
10 min read
Deals
Samsung Bio Nabs $1B Manufacturing Contract With Undisclosed US Pharma
Samsung Biologics announced Tuesday it has signed its largest contract ever—a $1.06 billion manufacturing deal with an unnamed pharmaceutical company headquartered in the U.S.
July 2, 2024
·
2 min read
·
Tristan Manalac
FDA
Samsung Bioepis Gets FDA Approval for Biosimilar of J&J’s Stelara
Pyzchiva, developed by Samsung Bioepis, will be commercialized in the U.S. by Sandoz with the license period beginning on Feb. 22, 2025, according to a settlement and licensing agreement with Johnson & Johnson’s Janssen Biotech.
July 1, 2024
·
1 min read
·
Tyler Patchen
Press Releases
Samsung Bioepis Receives Positive CHMP Opinion for Denosumab Biosimilars, OBODENCE™ and XBRYK™
November 15, 2024
·
6 min read
Press Releases
Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™
November 18, 2024
·
8 min read
Press Releases
Samsung Biologics reports third quarter 2024 financial results
October 23, 2024
·
4 min read
Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation
Samsung Bioepis Co., Ltd. issued its 2024 sustainability report, underscoring its progress toward building more sustainable and socially responsible practices in access to medicines, R&D innovation, and product quality and patient safety.
June 25, 2024
·
5 min read
Business
Samsung Biologics Reports First Quarter 2024 Financial Results
Samsung Biologics, a global contract development and manufacturing organization, announced financial results for the first quarter of fiscal year 2024.
April 24, 2024
·
4 min read
Press Releases
Samsung Biologics signs largest manufacturing deal with Asia-based pharmaceutical company
October 22, 2024
·
3 min read
1 of 22,229
Next
